News & Updates
Filter by Specialty:
Real-world data back CV safety of JAK inhibitors
28 Jun 2023
byAudrey Abella
Two real-world studies presented at EULAR 2023 reflected the cardiovascular (CV) safety of Janus kinase inhibitors (JAKi*) in patients with rheumatoid arthritis (RA).
Real-world data back CV safety of JAK inhibitors
28 Jun 2023Novel genetic marker predicts CHD risk in Chinese patients with T2DM
27 Jun 2023
bySarah Cheung
Researchers from the Chinese University of Hong Kong (CUHK) have discovered PDE1A rs10171703 as a novel genetic marker for coronary heart disease (CHD) in Chinese patients with type 2 diabetes mellitus (T2DM), indicating its potential utility for predicting CHD risk in this patient population.
Novel genetic marker predicts CHD risk in Chinese patients with T2DM
27 Jun 2023Debunking the myth: There is no ‘obesity paradox’, new data suggest
26 Jun 2023
byAudrey Abella
Using alternative anthropometric measurements, a post hoc analysis that used data from the PARADIGM-HF* trial debunked the BMI-related ‘obesity paradox’ in a large cohort of patients with chronic heart failure with reduced ejection fraction (HFrEF).